ONCY - Oncolytics Biotech Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Current Price & Safety Score Price: 0.47 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): -94.89 StockBond Score: -5.97 Company Description Oncolytics Biotech Inc a clinicalstage biopharmaceutical company engages in the research development and commercialization of oncology treatments The company develops pelareorep an intravenously delivered immunotherapeutic agent for the treatment of hormone receptorpositive human epidermal growth factor 2negative advanced and metastatic breast cancer metastatic pancreatic ductal adenocarcinoma and anal cancer It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors atezolizumab for use in its ongoing sponsored studies Oncolytics Biotech Inc was incorporated in 1998 and is headquartered in Calgary Canada